What is pharmacoeconomics?
Pharmacoeconomics is an area of economy that focuses on comparing the price of various pharmaceutical treatments and the price of non -pharmaceutical medical treatments. Farmacoeconomics uses four areas to evaluate treatment treatment. It is an analysis of the cost of efficiency, cost and benefits analysis, analysis of cost minimization and cost analysis. The cost of drug treatment is considered against the effectiveness of the drug. The cost of drug treatment includes acquisition costs, participation of the doctor and the cost of nursing for drug administration. The effectiveness of drug treatment is measured in tangible measures such as the length of stay in the hospital, the necessary treatment time and the mortality rate. This allows the actual cost of treating drugstores to compare in units of money in favor of the patient. Giving monetary value to the benefits they receive patients facilitate comparison in a meaningful way that the benefits of treatment are related to their costs. The cost and yield analysis also takes into account non -medical factors, such as the level of education of pharmacists and doctors.The central idea is to consider the benefits of treatment, but also to analyze the costs of different drug treatment and try to provide treatment with the lowest costs while ensuring the best benefit to the patient.
Analysis of minimization of costs is relatively simple. With two drug treatment options, if both are equally effective, it is at least selected for use. This is particularly important in communities where medical financing is strictly limited. The intention is to choose cheaper two equally effective drug treatments. The emphasis on minimizing costs is strictly proved that all compared treatment are equally effective and treatment that is not equally effective cannot be compared by analyzing the cost minimization.
Cost analysis and cost occupancy focus on life expectancy and quality of life, as quantified in years of life with quality adaptation (QALY). In such an analysis, a cash value is assigned to one Qala. DrugThe therapy is then provided with costs and it is determined whether it increases the QALY human. Some medicines may be beneficial in the short term, but in fact they do not increase the length or quality of life of the patient. Other medicines do not seem to be so effective in the short term, but can increase human Qaly in the long run.
The quality of life is difficult to measure. Some quality indicators may be the number of visits to the hospital, the level of pain over time and the duration of the disease. Patients' ability to perform basic functions such as bathing, dressing and feeding themselves is also taken into account. This may seem cold bloody, but it is necessary to try to understand whether treatment improves human life.
Pharmacoeconomics is trying to balance the real limits of health care financing with patient needs. Pharmacoeconomics is about finding better treatments for less money. It stores strict treatment testing to determine their effectiveness except their costs. Also focuses on where the cost can be nApreciated to the actual cost of medicinal therapy and can provide empirical evidence of the effective changes to be made.